Skip to content

Clinical trials

Terminated Phase 2 Melanoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Phase: Phase 2 Status: Terminated Clear all

167 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20033
20046
20055
20063
20075
200813
20095
20106
201114
20128
201316
201413
20155
20164
20179
20188
20197
20204
202111
20229
20234
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated167

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)24
GlaxoSmithKline4
M.D. Anderson Cancer Center4
National Institutes of Health Clinical Center (CC)3
Providence Health & Services3
University Hospital Tuebingen3
Vanderbilt-Ingram Cancer Center3
Astellas Pharma Inc2
Bristol-Myers Squibb2
Canadian Cancer Trials Group2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma167
Neoplasm Metastasis17
Carcinoma, Renal Cell15
Skin Neoplasms15
Brain Neoplasms13
Carcinoma, Non-Small-Cell Lung12
Neoplasms9
Breast Neoplasms7
Pancreatic Neoplasms7
Ovarian Neoplasms6

Trials

Showing 1 to 25 of 167. Each trial links to its page on Pharma Observatory.

67 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.